🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is a placebo-controlled, double-blind, randomized, phase 3 study ...
Status
Completed
Location
East Valley Diabetes & Endocrinology
Start Date
2024-03-01
Trial ID
NCT06005597
This study will be a placebo-controlled, double-blind, randomized, phase 2 ...
Status
Completed
Location
Pinnacle Research Group
Start Date
2021-02-18
Trial ID
NCT04753606
Treatments Being Tested
This study will be a placebo-controlled, double-blind, randomized, phase 3 ...
Status
Active Not Recruiting
Location
Advanced Cardiovascular LLC
Start Date
2022-02-07
Trial ID
NCT05202509
Treatments Being Tested
The goal of this clinical trial is to learn if Obicetrapib works to change ...
Status
Recruiting
Location
Excellence Medical Research
Start Date
2025-09-09
Trial ID
NCT06982508
Treatments Being Tested
This Phase 3, randomized, double-blind, active-controlled study evaluates t...
Status
Recruiting
Location
FutureMeds North Tees
Start Date
2026-05-06
Trial ID
NCT07614958
Treatments Being Tested
This study will be a placebo-controlled, double-blind, randomized, phase 2 ...
Status
Completed
Location
Nippon Kokan Fukuyama Hospital
Start Date
2022-06-27
Trial ID
NCT05421078
Treatments Being Tested
This study will be a placebo-controlled, double-blind, randomized, phase 3 ...
Status
Completed
Location
Site 01022
Start Date
2022-07-25
Trial ID
NCT05425745
Treatments Being Tested
This placebo-controlled, double-blind, randomized, Phase 3 study is being c...
Status
Active Not Recruiting
Location
NGMR
Start Date
2024-05-16
Trial ID
NCT06305559
Treatments Being Tested
This study will be a placebo-controlled, double-blind, randomized, phase 2 ...
Status
Completed
Location
Velocity Clinical Research - Westlake d.b.a National Research Institute
Start Date
2022-03-09
Trial ID
NCT05266586
Treatments Being Tested
To determine the treatment effect with obicetrapib (10 mg) on the fractiona...
Status
Active Not Recruiting
Location
Archna Bajaj, MD
Start Date
2023-12-01
Trial ID
NCT05972278
Treatments Being Tested